Patient-reported frequency, awareness and patient-physician communication of hypoglycaemia in Belgium

References

• Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence in adults for 2013 and projections for 2035 for the IDF diabetes Atlas. Diabetes Res Clin Pract. 2014;103(2):137–49.
   Web of Science ®Google Scholar
• Han Cho N, Whiting D, Guariguata L. IDF Diabetes Atlas Sixth Edition, 2013. Available from: www.idf.org/diabetesatlas
   Google Scholar
• UK Hypoglycemia Study Group. Risk of hypoglycemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia. 2007;50:1140–7.
   PubMed Web of Science ®Google Scholar
• Davis RE, Morissey M, Peters JR, Wittrup-Jensen K, Kennedy-Martin T, Currie CJ. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin. 2005;21(9):1477–83.
   Web of Science ®Google Scholar
• Lundkvist J, Berne C, Bolinder B, Jonsson L. The economic and quality of life impact of hypoglycemia. Eur J Health Econ. 2005;6(3):197–202.
   Google Scholar
• European Medicines Agency Committee for Medical Products for Human Use (CHMP). Guidelines on clinical investigation of medical products in the treatment or prevention of diabetes mellitus. 2012. European Medicines Agency.
   Google Scholar
• American Diabetes Association Workgroup on Hypoglycemia. Defining and Reporting Hypoglycemia in Diabetes. Diabetes Care. 2005;28(5):1245–9.
   Web of Science ®Google Scholar
• Oyer DS. The science of hypoglycemia in patients with diabetes. Curr Diabetes Rev. 2013;9(3):195–208.
   Google Scholar
• Donnelly LA, Morris AD, Frier BM, Ellis JD, Donnan PT, Durrant R, et al. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabet Med. 2005;22(6):749–55.
   Web of Science ®Google Scholar
• Pramming S, Thorsteinsson B, Bendtson I, Binder C. Symptomatic hypoglycemia in 411 type 1 diabetic patients. Diabet Med. 1991;8(3):217–22.
   Web of Science ®Google Scholar
• Pedersen-Bjergaard U, Pramming S, Thorsteinssen B. Recall of severe hypoglycemia and self-estimated state of awareness in type 1 diabetes. Diabetes Metab Res Rev. 2003;19(3):232–40.
   Web of Science ®Google Scholar
• Kristensen PL, Hansen LS, Jespersen MJ, Pedersen-Bjergaard U, Beck-Nielsen H, Christiansen JS, et al. Insulin analogues and severe hypoglycaemia in type 1 diabetes. Diabetes Res Clin Pract. 2012;96(1):17–23.
   Web of Science ®Google Scholar
• Pedersen-Bjergaard U, Pramming S, Heller SR, Wallace TM, Rasmussen AK, Jørgensen HV, et al. Severe hypoglycemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab Res Rev. 2004;20(6):479–86.
   Web of Science ®Google Scholar
• Zinman B. Newer insulin analogs: advances in basal insulin replacement. Diabetes Obes Metab. 2013;15(S1):6–10.
   Google Scholar
• Fonseca VA. New developments in diabetes management: medications of the 21st century. Clin Ther. 2014;36(4):477–84.
   Web of Science ®Google Scholar
• Inzucchi SE, Bergenstal RM, Buse JB Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2012;55(6):1577–96.
   Web of Science ®Google Scholar
• Östenson GC, Geelhoed-Duijvestijn P, Lahtela J, Weitgasser R, Markert Jensen M, Pedersen-Bjergaard U. Self-reported non-severe hypoglycaemic events in Europe. Diabet Med. 2014;31(1):92–101.
   Web of Science ®Google Scholar
• Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes. 2008;57(12):3169–76.
   Web of Science ®Google Scholar
• Smith CB, Choudhary P, Pernet A. Hypoglycemia unawareness is associated with reduced adherence to therpeutic decisions in patients with type 1 diabetes. Diabetes Care. 2009;32(7):1196–8.
   Web of Science ®Google Scholar
• Wild D, Von Maltzahn R, Brohan E, Christensen T, Clauson P, Gonder-Frederick L. A critical review of literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education. Patient Educ Couns. 2007;68:10–5.
   PubMed Web of Science ®Google Scholar
• Leiter LA, Yale JF, Chiasson JL, Harris S, Kleinstiver P, Sauriol L. Assassement of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemia management. Can J Diabetes. 2005;29:1–7.
   Google Scholar
• Henderson JN, Allen KV, Deary IJ, Frier BM. Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med. 2003;20(12):1016–21.
   Web of Science ®Google Scholar
• Geelhoed-Duijvestijn PH, Pedersen-Bjergaard U, Weitgasser R, Lahtela J, Jensen MM, Ostenson CG. Effects of patient-reported non-severe hypoglycemia on healthcare resource use, work-time loss, and wellbeing in insulin-treated patients with diabetes in seven European countries. J Med Econ. 2013;16(12):1453–61.
   Google Scholar
• Schopman JE, Geddes J, Frier BM. Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated type 2 diabetes. Diabetes Res Clin Prac. 2010;87:64–8.
   PubMed Web of Science ®Google Scholar
• Akram K, Pedersen-Bjergaard U, Carstensen B, Borch-Johnsen K, Thorsteinsson B. Frequency and risk factors of severe hypoglycaemia in insulin-treated Type 2 diabetes: a cross-sectional survey. Diabet Med. 2006;23(7):750–6.
   Web of Science ®Google Scholar
• Holt RI, Nicolucci A, Kovacs Burns K, Escalante M, Forbes A, Hermanns N, et al. DAWN2 Study Group. Diabetes Attitudes, Wishes and Needs second study (DAWN2TM): cross-national comparisons on barriers and resources for optimal care–healthcare professional perspective. Diabet Med. 2013;30:789–98.
   PubMed Web of Science ®Google Scholar